Table 1

Characteristics of the articles included in this systematic review

Remission
AuthorsCountry/regionYear of publicationPatientsEthnicity, %Cross-sectional or longitudinalFollow-up yearsNOS
CaucasianAsianMestizo/HispanicAfrican descentOthers
Drenkard et al4Mexico1996667NRNRNRNRNRLongitudinal11.65
Medina-Quiñones et al5UK201653255.318.0NR10.96.8Longitudinal12.07
Polachek et al7*Canada2017620NRNRNRNRNRLongitudinal4.07
Zen et al16Italy2017293100.00.00.00.00.0Longitudinal7.07
Ugarte-Gil et al14*Latin America2017135041.8NR42.711.73.8Longitudinal2.48
Tsang-A-Sjoe et al15*The Netherlands201718368.3NRNRNR31.7Longitudinal5.08
Mok et al3Hong Kong20177690.0100.00.00.00.0Longitudinal≥5.07
Petri et al18*USA2018135655.0NRNR38.07.0Longitudinal3.87
Tani et al11*Italy2018115NRNRNRNRNRLongitudinal≥5.08
Poomsalood et al24*Thailand2019237NRNRNRNRNRCross-sectionalNR7
Alarcon et al20*USA201955828.00.035.037.00.0LongitudinalNR8
Ugarte-Gil et al25USA2019483NRNRNRNRNRLongitudinalNR7
Mathian et al26*France2019407NRNRNRNRNRLongitudinal1.07
Golder et al27Asia Pacific2019170710.187.7NRNR2.2Longitudinal2.26
Reátegui-Sokolova et al28*Peru2019315NRNRNRNRNRLongitudinalNR9
Margiotta et al29Italy2019136NRNRNRNRNRCross-sectionalNR7
Fasano et al30Italy2019294NRNRNRNRNRLongitudinal9.07
Goswami et al31India2019126NRNRNRNRNRLongitudinal0.57
Tsang-A-Sjoe et al15The Netherlands201915469.5NRNRNR30.5Longitudinal2.07
Ugarte-Gil et al33*Peru2020208NRNRNRNRNRLongitudinal2.29
Floris et al34 *Italy2020116100.00.00.00.00.0Longitudinal1.58
Saccon et al35Italy2020646NRNRNRNRNRLongitudinal5.09
Jakez-Ocampo et al36Mexico2020132NRNRNRNRNRCross-sectionalNR6
Nikfar et al37Iran2021193NRNRNRNRNRLongitudinal8.08
LDA
AuthorsCountry/
region
Year of publicationPatientsEthnicity, %Cross-sectional or longitudinalFollow-up yearsNOS
CaucasianAsianMestizo/
Hispanic
African descentOthers
Polachek et al7*Canada2017620NRNRNRNRNRLongitudinal4.07
Ugarte-Gil et al14*Latin America2017135041.8NR42.711.73.8Longitudinal2.48
Tsang-A-Sjoe et al15*The Netherlands201718368.3NRNRNR31.7Longitudinal5.08
Golder et al39Asia Pacific201714228.090.0NRNR2.0Cross-sectionalNR7
Tani et al11*Italy2018115NRNRNRNRNRLongitudinal≥58
Zen et al17Italy2018293100.00.00.00.00.0Longitudinal7.09
Petri et al18*USA2018135655.0NRNR38.07.0LongitudinalNR7
Poomsalood et al24*Thailand2019237NRNRNRNRNRCross-sectionalNR7
Alarcon et al20 *USA201955828.00.035.037.00.0LongitudinalNR8
Ugarte.Gil et al25*USA2019483NRNRNRNRNRLongitudinalNR7
Mathian et al26*France2019407NRNRNRNRNRLongitudinal1.07
Golder et al38Asia Pacific2019170710.187.7NRNR2.2Longitudinal2.26
Reategui-Sokolova et al28*Peru2019315NRNRNRNRNRLongitudinalNR9
Ugarte-Gil et al33*Peru2020243NRNRNRNRNRLongitudinal2.27
Sharma et al40Norway2020206100.00.00.00.00.0Longitudinal10.06
Yeo et al41Australia202020052.039.5NRNR8.5Longitudinal2.19
Floris et al34*Italy2020116100.00.00.00.00.0Longitudinal1.58
Louthrenoo et al42Thailand2020337NRNRNRNRNRLongitudinal3.28
Kang et al43Korea2021299NRNRNRNRNRLongitudinal4.08
  • *These articles were included for remission and LDA.

  • LDA, low disease activity; NOS, Newcastle-Ottawa Scale; NR, not reported.;